A study of Ivermectin invited the entire population of Itajaí, Brazil. In the absence of contrain indications, ivermectin was offered as an optional treatment.
This very large study found 44% lower infection and 68% lower deaths rates from twice a month usage of low dose Ivermectin.
Conclusion: In this large PSM study, regular use of ivermectin as a prophylactic agent was associated with significantly reduced COVID-19 infection, hospitalization, and mortality rates.
This is a peer reviewed study.
Read the rest of the story HERE:
At www.nextbigfuture.com
At www.nextbigfuture.com
3
2
2
